🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
14/12/2018 0,5248 USD
14/09/2018 0,4580 USD
14/06/2018 0,4580 USD
14/03/2018 0,4580 USD
14/12/2017 0,4580 USD
14/09/2017 0,4485 USD
13/06/2017 0,4485 USD
13/03/2017 0,4485 USD
13/12/2016 0,4485 USD
13/09/2016 0,4389 USD
13/06/2016 0,4389 USD
11/03/2016 0,4389 USD
11/12/2015 0,4389 USD
11/09/2015 0,4294 USD
11/06/2015 0,4294 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/03/2020 65,28 67,16 63,69 65,10 -1,20% 5,31% 18.311.494
24/03/2020 65,83 66,56 64,11 65,89 +3,99% 3,71% 19.901.939
23/03/2020 67,05 68,33 62,26 63,36 -6,95% 9,05% 18.375.003
20/03/2020 66,36 69,18 65,36 68,09 +0,89% 5,75% 23.075.912
19/03/2020 68,08 69,52 65,75 67,49 -1,26% 5,54% 19.268.738
18/03/2020 68,18 71,24 65,68 68,35 -3,83% 8,16% 18.558.508
17/03/2020 68,37 72,59 68,11 71,07 +6,52% 6,55% 24.745.795
16/03/2020 67,53 72,61 64,05 66,72 -8,90% 12,67% 20.808.354
13/03/2020 72,73 73,69 68,95 73,23 +3,09% 6,52% 25.857.094
12/03/2020 70,99 74,48 69,90 71,04 -6,06% 6,45% 22.664.782
11/03/2020 76,17 76,49 74,46 75,62 -3,38% 2,67% 14.274.179
10/03/2020 76,79 78,42 73,95 78,26 +3,88% 5,82% 17.527.486
09/03/2020 74,43 77,02 73,46 75,34 -3,94% 4,78% 18.942.810
06/03/2020 76,31 78,84 75,79 78,44 +0,76% 3,99% 14.208.574
05/03/2020 77,80 78,98 77,23 77,84 -1,68% 2,24% 15.017.840
04/03/2020 77,77 79,27 76,22 79,17 +4,85% 3,91% 20.224.199
03/03/2020 77,67 78,63 74,34 75,51 -2,75% 5,52% 17.394.599
02/03/2020 73,60 77,81 73,55 77,64 +6,28% 5,80% 18.840.525
28/02/2020 73,17 73,94 70,78 73,05 -1,95% 4,32% 29.246.117
27/02/2020 77,01 78,01 74,43 74,50 -2,33% 4,65% 15.734.253
26/02/2020 76,97 77,89 76,12 76,28 -0,41% 2,31% 11.940.283
25/02/2020 77,80 78,19 76,19 76,59 -1,30% 2,56% 13.171.683
24/02/2020 76,92 78,81 76,88 77,61 -1,23% 2,51% 13.734.145
21/02/2020 78,43 78,85 77,97 78,57 -0,18% 1,12% 9.295.970
20/02/2020 78,45 79,04 77,98 78,71 +0,60% 1,35% 10.941.330
19/02/2020 79,27 79,30 77,83 78,24 -0,56% 1,85% 11.740.220
18/02/2020 79,08 79,30 78,49 78,68 -0,23% 1,03% 10.017.308
14/02/2020 78,46 79,01 77,93 78,86 +0,83% 1,37% 8.743.464
13/02/2020 79,13 79,13 77,72 78,22 -1,54% 1,78% 19.388.734
12/02/2020 81,15 81,33 79,10 79,44 -2,35% 2,74% 19.630.926